To The Moon

$NEBIUS(NBIS)$ Is this stock a buy now?  My take: Cautiously bullish, but I wouldn’t go all-in. Nebius Group (NASDAQ: NBIS) is one of the more interesting ways to invest in the AI infrastructure boom. It provides GPU computing capacity and cloud services for AI workloads. My verdict as of October 20, 2026: NBIS is worth considering for a long-term growth portfolio, but the upcoming earnings report makes the timing tricky. The stock has recently pulled back significantly, which could create an opportunity. However, its enormous infrastructure spending and demanding valuation mean that a cheaper share price doesn’t automatically make it a bargain. 1. What’s happening with NBIS right now? According to the latest market data available, NBIS close

$Amazon.com(AMZN)$ some good price movement today!

The market has finally given investors something we have not had much of this year: Better prices. But a stock falling 10% does not automatically make it 10% more attractive. My rule for this dip is simple: Buy companies where the price has deteriorated faster than the business. Right now, my shopping list is MU, NVDA, META, CRCL and QQQ, but at very different levels. 🥇 MU: MY HIGHEST-CONVICTION DIP BUY Micron has been hit by the combination of memory-cycle fears, CXMT concerns and the broader technology selloff. But the question is whether HBM demand and earnings power have deteriorated as quickly as the share price. I do not think they have. 🚦 My levels 🟡 $860-$890: Starter position 🟢 $800-$840: Preferred Pick 🟢 $740-$790: Strong Pick 🔴 Below $740: Reassess the thesis If MU reaches $800-

📊 Market Recap Moderna, Inc. ('MRNA') closed at $226.89 on October 20, 2026, up +4.07% with an intraday swing of 9.53%. After-hours trading pushed the price further to $227.20, indicating continued buying interest. The stock now sits just 6.4% below its 52-week high of $242.29, driven by renewed optimism around its mRNA cancer vaccine pipeline. 🚀 Key Drivers Cancer Vaccine Catalyst: NIH is reportedly accelerating a public-private partnership for cancer vaccine development, reigniting enthusiasm for Moderna's oncology platform. Nasdaq 100 Inclusion: Moderna's addition to the Nasdaq 100 index triggered passive fund inflows and institutional rebalancing. Massive 2026 Rally: The stock has surged over 650% year-to-date, with positive Phase III combination data for its mRNA cancer vaccine reshap

📊 Market Recap As of the close on October 20, 2026 (Eastern Time), 'META' finished at $705.44, down -0.55% from the prior session. The stock traded in a range of $693.86 to $708.83, settling roughly 9.5% below its 52-week high of $779.82 and approximately 14.6% above the immediate pivot zone of $615.73. The tape suggests a fading momentum environment, with price action consolidating below the recent pre-market reference of $707.83. 🚀 Key Drivers Open-Source AI Expansion: Meta has reportedly released a new open-source AI model in collaboration with Apple to run on Mac devices, reinforcing its position in the open-model ecosystem. Capital Flow Shift: Five-day capital flow data shows early-week outflows transitioning to inflows of 33.0 million on October 15 and 34.8 million on October 16, ind

📊 Market Recap As of the latest close on October 20, 2026, 'PLTR' finished at $194.15, up +4.36% with an intraday gain of $8.12. The stock traded as high as $196.99 and as low as $186.16, with amplitude of 5.82%. The closing price is approximately 8.8% below its 52-week high of $212.94, yet solidly above the 52-week low of $106.37, reflecting a strong rebound in the AI-driven intelligence sector. 🚀 Key Drivers AI Momentum Reaccelerates: Palantir continues to benefit from accelerating demand for AI-enabled data analytics across government and commercial clients, reinforcing its premium growth narrative. Institutional Accumulation: Major shareholders including BlackRock, Vanguard, and State Street maintain large positions, while Peter Thiel retains a significant stake, signaling long-term co

📊 Market Recap As of October 20, 2026, Eastern Time, 'AAOI' closed at $78.20, up +3.48% from previous close of $75.57. The stock remains approximately 66.5% below its 52-week high of $233.67, reflecting a prolonged downtrend despite today's rebound. 🚀 Key Drivers Oversold Technical Bounce: RSI(6) fell to 19.33 in recent sessions, deeply oversold territory, triggering short-covering and bargain hunting that drove today's rebound. AI Optical Networking Demand: As a key supplier of optical transceivers and laser components for AI data centers, 'AAOI' continues to benefit from sustained capex spending in high-speed interconnect infrastructure. Analyst Target Upside: With a consensus target price of $140.17, the stock trades at a significant discount to institutional expectations, supporting sp

📊 Market Recap As of October 20, 2026, CoreWeave, Inc. ('CRWV') closed at $61.12, down -0.44% for the day. The stock hit a new 52-week low of $59.25 during the session, marking a devastating -57% drawdown from its 52-week high of $141.79. With a trading volume of 100 million shares and a turnover rate of 18.15%, the stock remains in a firmly bearish technical structure as selling pressure intensifies. 🚀 Key Drivers Founder Selloff and Credit Stress: Reports indicate CoreWeave's three co-founders cashed out over $3.3 billion before the crash. The company's 2032 bonds have fallen into distressed territory, with CDS spreads surging to 1,117 basis points and an implied default probability of 63%, signaling deep concerns over its debt servicing capacity. Analyst Defense vs. Market Reality: Dan

📊 Market Recap As of October 20, 2026 (Eastern Time), Intel closed at $92.03, up +2.43% on the day. The stock remains far below its 52-week high of $142.35, but the latest session shows early signs of stabilization after a prolonged downtrend, with the price reclaiming the $92 level and moving closer to the $95 short-term resistance. 🚀 Key Drivers JPMorgan Upgrade: Intel shares rose about 2.6% in Monday trading after JPMorgan upgraded the stock to Neutral with an $85 price target, signaling reduced downside risk and a shift in institutional sentiment. Capital Flow Turnaround: Recent 5-day capital flow data shows large inflows on October 16 (¥50.26 million), suggesting some short-term buying interest returning after mixed flows earlier in the week. Short Interest Easing: Short volume ratio

📊 Market Recap As of October 20, 2026, 'NBIS' closed at $170.24, up +2.88% from the previous session's $165.47. The stock traded between $166.59 and $176.69, still sitting roughly 43% below its 52-week high of $299.86, but well above the 52-week low of $73.52. The rebound suggests early stabilization after a prolonged pullback, with buyers stepping in near the $168 support zone. 🚀 Key Drivers AI Cloud Recovery: AI cloud service providers rallied collectively in late September, with 'NBIS' gaining nearly 6% in a single session amid renewed investor interest in AI infrastructure. Pricing Power Signal: A price increase announcement in mid-September triggered a notable pre-market surge, reinforcing the market's view that Nebius can monetize its AI cloud capacity more aggressively. Institutiona

📊 Market Recap As of October 20, 2026, 'SKHY' closed at $142.87, surging +4.67% with an intraday range of $141.27 - $148.00. The stock remains approximately 28.5% below its 52-week high of $199.87, while sitting 14.5% above its 52-week low of $124.80. Pre-market strength on October 19 at $142.86 signaled renewed buying interest, followed by after-hours confirmation at $143.21. 🚀 Key Drivers AI Memory Supercycle: SK Hynix remains the dominant supplier of HBM (High Bandwidth Memory) to NVIDIA, with AI-driven demand continuing to tighten supply. Technical Rebound from Oversold: RSI(6) has recovered from 8.81 to 24.82, exiting extreme oversold territory and triggering momentum-driven buying. Institutional Accumulation: BlackRock increased its stake by 921,224 shares, while Capital Research add

📊 Market Recap As of the October 20 close, 'SPCX' finished at $147.96, up +1.32% on the day. The stock traded in a narrow range between $146.83 and $151.01, closing roughly 34.4% below its 52-week high of $225.64. With Q3 earnings due after the close Tuesday, investors are positioning for a potential breakout above the immediate resistance zone near $161.66. 🚀 Key Drivers Q3 Earnings Positioning: Shares climbed Monday as investors positioned ahead of the company's Q3 report, due after the market close on Tuesday. Morgan Stanley Endorsement: Morgan Stanley reiterated an Overweight rating with a $300 price target, citing Starship Flight 15 as the biggest post-IPO catalyst since the debut. Spectrum Acquisition: SpaceX's pending purchase of 800MHz spectrum from Grain Management, awaiting FCC a

1. This Week's Market Overview US stocks face a triple test: hotter inflation, pressure on AI financing, and earnings that need to prove the story. September CPI rose to 3.7%, and higher oil prices made the market rethink Fed rate-hike risk. Meanwhile, funding costs for AI cloud companies like CoreWeave are climbing. Investors are starting to ask: can huge AI spending actually turn into enough revenue and profit? Semiconductors fell for eight straight days, showing money is rethinking the growth premium on AI hardware. But the market isn't fully bearish: companies with AI platforms and ways to make money from products, like META and GOOGL, still have bright spots. Money is also moving into defensive sectors like healthcare. The key this week isn't whether AI demand exists. It's whether AI

CoreWeave fell 11.91% Friday to roughly $63, and I think investors focusing only on GPU demand are looking at the wrong variable. Demand is not CoreWeave's immediate problem. CoreWeave reported a $104 billion revenue backlog at the end of Q2, before more than $25 billion of additional early-Q3 commitments. Recent capacity has also been contracted at higher prices. The problem is what it costs to finance all that growth. CoreWeave bonds that were issued around a 9.7% yield in June recently traded near 15%. That changes the equation. AI demand can remain spectacular while the equity performs terribly if the cost of funding the infrastructure rises faster than its economics improve. 🔴 THE NUMBER I CARE ABOUT IS NOT GPU ORDERS CoreWeave needs enormous capital before much of its contracted reve

AI spending is booming. But where are the returns? After a difficult week for technology stocks, Wall Street faces an important test. Investors are no longer satisfied with ambitious AI plans and rising infrastructure spending. They want evidence that those investments can generate sustainable revenue, profits and cash flow. This week, three major companies will offer different perspectives on that challenge: SpaceX, Meta and Tesla. According to the earnings previews, SpaceX reports on Tuesday, followed by Meta and Tesla on Wednesday. Their results could help shape market sentiment after the recent AI-related sell-off.  🚀 1. SpaceX (SPCX): Can Starlink Fund the AI Ambition? SpaceX is building more than a rocket business. Starlink’s satellite internet operations provide a growing source of